TNF-alpha Modulation for Treatment of Alzheimer's Disease: A 6-Month Pilot Study

ABSTRACT: CONTEXT: Current pharmacologic treatments for Alzheimer's disease (AD) do not prevent long-term clinical deterioration. Tumor necrosis factor (TNF)-alpha, a proinflammatory cytokine, has been implicated in the pathogenesis of AD. OBJECTIVE: To investigate the use of a biologic TNF-alp...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tobinick, Edward, Gross, Hyman, Weinberger, Alan, Cohen, Hart
Médium: Artigo
Jazyk:Inglês
Vydáno: Medscape 2006
Témata:
MedGenMed Neurology & Neurosurgery
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1785182/
https://ncbi.nlm.nih.gov/pubmed/16926764
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky